ClinicalTrials.Veeva

Menu

Deep Learning With MRI-based Multimodal-data Fusion Enhanced Postoperative Risk Stratification of Breast Cancer

Sun Yat-sen University logo

Sun Yat-sen University

Status

Completed

Conditions

Breast Cancer

Treatments

Other: MRI

Study type

Observational

Funder types

Other

Identifiers

NCT06546072
YSEC-KY-KS-2019-054-001

Details and patient eligibility

About

Breast cancer poses a significant global health challenge, especially among women, with high rates of recurrence and distant spread despite early interventions. The timely identification of metastasis risk and accurate prediction of treatment strategies are critical for improving prognosis. However, the complex heterogeneity of breast tumors presents challenges in precise prognosis prediction. Therefore, the development of innovative methods for tumor segmentation and prognosis assessment is essential.

The research conducted is a multicenter study that enrolled 1,199 non-metastatic breast cancer patients from four independent centers. Our study leverages the advancements in artificial intelligence (AI) to address this challenge. This study is the first successful application of MRI-based multimodal prediction system to precisely identify the risk of postoperative recurrence in breast cancer patients.

Enrollment

1,199 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Histologically confirmed stage I-III invasive BC
  • Age ≥ 18 years
  • The patient having undergone surgery
  • The existence of MRI scans

Exclusion criteria

  • Lacked pathological results
  • Had other, simultaneous malignancies
  • Had MR imaging issues were excluded

Trial design

1,199 participants in 4 patient groups

Training cohort
Description:
We randomly assigned 569 patients from Sun Yat-sen Memorial Hospital of Sun Yat-sen University (SYSMH; Guangzhou, China) at a ratio of 3:1 to training (n = 456) and internal-validation (n = 113) cohorts.
Treatment:
Other: MRI
Internal validation cohort
Description:
We randomly assigned 569 patients from Sun Yat-sen Memorial Hospital of Sun Yat-sen University (SYSMH; Guangzhou, China) at a ratio of 3:1 to training (n = 456) and internal-validation (n = 113) cohorts.
Treatment:
Other: MRI
External testing cohort 1
Description:
432 from Sun Yat-sen University Cancer Center (SYSUCC; Guangzhou, China) into external testing cohort 1.
Treatment:
Other: MRI
External testing cohort 2
Description:
198 from Dongguan Tungwah Hospital (DTH; Dongguan, China) and Shunde Hospital of Southern Medical University (SDHSMU; Guangzhou, China) into external testing cohort 2.
Treatment:
Other: MRI

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems